Mark E. Dunlap, MD - Department of Physiology and Biophysics

More documents

Recommendations

Info

Mark E. Dunlap, MDCurriculum Vitae, page 22Heart Failure Management 2001, Amelia Island, FloridaSeptember 2001 US Representative, CHARM Steering Committee Meeting, Stockholm, SwedenSeptember 2001 “Pathophysiology of Heart Failure due to diastolic dysfunction”Common Cardiac Approaches: Focused Approaches to Evaluation and ManagementUniversity Hospitals of Cleveland, Cleveland, OhioSeptember 2001 “Acutely Decompensated Heart Failure: Presentation and Management”Heart Failure Society of America Meeting, Washington, DCOctober 2001“Unusual Features of Heart Failure—sleep disordered breathing in patients with heartfailure”; Santa Fe Colloquium on Cardiovascular Therapy, Santa Fe, New MexicoSponsored by the American College of CardiologyNovember 2001 “What is the Role of Angiotensin II Receptor Antagonist in the Treatment of Heart Failure?”The First WHF Global Conference on Cardiovascular Clinical Trials, Hong Kong, ChinaNovember 2001 “Trial Presentation: IMPRESS/OVERTURE”The First WHF Global Conference on Cardiovascular Clinical Trials, Hong Kong, ChinaNovember 2001 “Strategies and Designs of Clinical Trials in Heart Failure – What Are AppropriateEndpoints?”The First WHF Global Conference on Cardiovascular Clinical Trials, Hong Kong, ChinaNovember 2001 “Update on Pathophysiology and Treatment of Heart Failure”Medical Grand Rounds, Logan Hospital, Logan, West VirginiaFebruary 2002 "Design and implementation of Cardiovascular Clinical Trials"University Hospitals of Cleveland Residents conferenceFebruary 2002 “Myths and Realities of Beta Blockade in Heart Failure”; CME Symposium on ABC’s ofHeart Failure, sponsored by Case Western Reserve University, Cleveland, OHMarch 2002“Neurohumoral Modulation in Heart Failure”Grand Rounds, West Allis Memorial Hospital, West Allis, WisconsinMarch 2002Co-Chairman, session on “Exercise and the Heart Failure Patient: ProvocativeObservations”, American College of Cardiology meetings, Atlanta, GeorgiaMarch 2002“Neurohumoral Modulation in Heart Failure”Medical Grand Rounds, McGuire VA Medical Center, Richmond, VirginiaJune 2002“Using Quality Reports in the CHARM Trial”CHARM International Monitors Meeting, Megève, FranceJuly 2002 Panel Discussion, “Role of the Heart Failure Clinic Team”, Heart Failure Management 2002:Established Therapy and New Frontiers, Amelia Island, FloridaAugust 2002“Beta-blocker use in patients with COPD and heart failure”Toprol-XL Core US Advisory Board Meeting, Mackinaw Island, MINovember 2002 Invited Speaker, “Beta Blockers as Part of the New Standard of Care in Heart Failure”;Medical Grand Rounds, St. Vincent Health Center, Erie, PennsylvaniaFebruary 2003 “Devices in Heart Failure” Workshop; CME symposium on ABC’s of Heart Failure,sponsored jointly by CWRU, University Hospitals, and The Cleveland ClinicApril 2003“Hyperthyroid heart disease”Morbidity and Mortality Rounds, University Hospitals of ClevelandApril 2003“Acute management of patients with atrial fib and flutter with rapid ventricular response”Morbidity and Mortality Rounds, Louis Stokes Cleveland VA Medical CenterMay 2003“Update on Heart Failure”; Advanced Practice Continuing Education Nursing SeriesLouis Stokes Cleveland VA Medical Center, Cleveland, OhioJune 2003“Legionnaire’s Myocarditis”
Mark E. Dunlap, MDCurriculum Vitae, page 23July 2003August 2003September 2003September 2003September 2003September 2003October 2003October 2003November 2003November 2003November 2003December 2003December 2003December 2003January 2004February 2004February 2004February 2004Morbidity and Mortality Rounds, Louis Stokes Cleveland VA Medical Center“Utilization of beta blockade in patients with potential contraindications”Heart Failure Management 2003: Established Therapy and New FrontiersAmelia Island, Florida“Myths of beta blockers use in patients with cardiovascular disease”Medical College of Wisconsin, Milwaukee, WI“Control of the circulation in heart failure: effects of exercise training”Trends in exercise physiology and cardiac rehabilitation Symposium, Rome, Italy“Effect of Candesartan on reduction of events in patients with HF and preservedsystolic function—results of the CHARM-Preserved study”Principle Investigators Meeting, Heart Failure Society of America, Las Vegas, NVCHARM program, Panel discussion; Satellite SymposiumHeart Failure Society of America, Las Vegas, NV“How to detect breathing-related disorders in patients with heart failure”Lunch and Learn Symposium, Heart Failure Society of America, Las Vegas, NV“Beta blocker therapy in congestive heart failure”29 th Annual Appleton Heart Institute Cardiovascular Conference, Appleton, WI“Heart failure in women”; Mini-Medical School SeriesCase Western Reserve University, Cleveland OH“New Therapeutic Strategies in HF Management: Results from the CHARM Program”CME Satellite Symposium—Data Talks! The latest chapter on ARBs in HFAmerican Heart Association Scientific Sessions, Orlando, FloridaAlso on the program: Marc Pfeffer, MD, PhD; Karl Swedberg, MD, PhD; Chris Granger,MD; James Young, MD. This program was recorded for a web-based CME module onTheHeart.org.Co-Chairman, session on “Featured Research: Novel Neuronal Mechanisms ofCardiovascular Dysregulation”, American Heart Association Meeting, Orlando, FloridaCo-Chairman, session on “Neurohumoral Control and Heart Failure”,American Heart Association Meeting, Orlando, Florida“Treatment of Diastolic Dysfunction”American Society of Hypertension Mid-Atlantic Chapter Meeting, Washington DCChairman, CHARM Educational Committee MeetingNew York City“Myths and Realities of beta blocker use in patients with HF”Cleveland Clinic Foundation, HF seminar series“Prevent, Protect, Prolong: The Role of Beta Blockersin the Fight Against Cardiovascular Disease”Pri-Med Steering Committee Co-ChairFaculty Training Meeting, Washington DC“Optimizing Subspecialty Outpatient and Procedure Clinics”Advanced Clinic Access Implementation meeting, Department of Veterans AffairsBaltimore, MD“Myths and Realities of beta blocker use in patients with HF”Cardiology Grand Rounds, University Hospitals of Cleveland, Cleveland, OH20 th Scientific Meeting of the International Society of Hypertension, Sao Paulo, BrazilSubmitted presentations: "New approaches in heart failure management"
Page 1 and 2: CURRICULUM VITAEMark Evans Dunlap,
Page 3 and 4: Mark E. Dunlap, MDCurriculum Vitae,
Page 5: Mark E. Dunlap, MDCurriculum Vitae,

Mark E. Dunlap, MD - Department of Physiology and Biophysics

Create successful ePaper yourself

Delete template?

Save as template?